THE USAGE OF MEDICINES AT THE CARDIOVASCULAR PATHOLOGIES IN DOGS AND CATS


  • I.S. Varkholiak Lviv National University of Veterinary Medicine and Biotechnologies
Keywords: dogs, cats, medications, heart, blood vessels, cardiomyopathies

Abstract

The review of literature about the pathology of a heart and vessels in dogs and cats is presented in the article. Pathologies of cardiovascular system occupy a leading position among the diseases of non-contagious etiology and are one of the major causes of death. The statistical data indicate that the heart diseases are detected in 5-10% of patients that are admitted to the doctor. The group of risk factor of the cardiovascular system pathology occurrence was found, in particular innate ability: dogs of small and medium breeds are predisposed to acquired valve disease (chronic valve disease, endocardiosis), while for dogs of big breed is peculiar the development of dilated cardiomyopathy (DCM) and diseases of pericardium. In particular the characteristic of such diseases are given: arrhythmogenic right ventricular cardiomyopathy (arrhythmogenic right ventricular dysplasia of dogs), dilated cardiomyopathy, hypertrophic cardiomyopathy, chronic degenerative disease of AV valves.

Recently several major researches were conducted in the sphere of cardiac insufficiency treatment, were introduced new methods of diagnostics, found new genetic peculiarities of certain pathologies and occurred new medicines, for example: imobendan, polisaturated fatty acids, sildenafil, levosimendan, torasemide, nebivolol, lisinopril, clopidogrel and others. However, data about the usage of new therapeutic preparations for cardiovascular system is not enough.

Thus, the need arise to conduct comprehensive researches of the mechanisms of medicine action, its interaction with other preparations, clinically efficiency of treatment and usage safety. 

Downloads

Download data is not yet available.

References

Stekol'nikov, A.A. (2009). Bolezni sobak i koshek. Kompleksnaja diagnostika i terapija. SPb (in Russian).

Kersten, U., Suter, P.F. (1998). Krovoobrashhenie. Bolezni sobak. M.: Akvarium, 414–449 (in Russian).

Zhulikova, O.A. (2016). Monitoring rasprostranenija serdechno–sosudistyh zabolevanij sredi koshek i sobak v g. Blagoveshhensk amurskoj oblasti. Dal'nevostochnyj agrarnyj vestnik. 2(38), 49–56 (in Russian).

Vinnikov, N.T. (2003). Veterinarnaja laboratornaja diagnostika. Saratov (in Russian).

Borgarelli, M. (2004). Comparison of primary mitral valve disease in German Shepherd dogs and in small breeds. J Vet Cardiol, 27 –34 (in Russian).

Bosvud, A. (2009). Klapannye poroki serdca u sobak. Fokus. 18(3), 25–31 (in Russian).

Kozlovskaja, N.G. (2013). Porodnaja predraspolozhennost' sobak i koshek k kardiologicheskim zabolevanijam. Rossijskij veterinarnyj zhurnal. 6, 32–35.

Buchanan, J.W., Bonagura, J.D. (1992). Causes and prevalence of cardiovascular disease. In: Kirk RW, (eds). Current veterinary therapy XI,. Philadelphia: WB Saunders. 647–655

Dimski, D.S., Hawkins E.C. (1988). Canine systemic hypertension. Compendium of Small Animal. 10, 1152–1155

Kittleson, M.D., Kienle R.D. (1998). Small animal cardiovascular medicine. St Louis: Mosby. 603

Fox, P.R., Sisson D., Moise N.S. (1999). (eds). Textbook of canine and feline cardiology, 2nd ed. Phildelphia: WB Saunders. 951

Ware, W.A., Keene B.W. (2000). Outpatient management of chronic heart failure. In Bonagura JD (ed). Current veterinary therapy XIII. Philadelphia: WB Saunders. 748–752.

Tilley, P.L., Francis W. K., Smith J., Oyama M.A. (2008). Manual of canine and feline cardiology copyright by Saunders, an imprint of Elsevier Inc. (Fourth edition) 105–106.

Linklater, A.J., Lichtenberger M.K., Tham D.H. (2007). Serum concentrations of cardiac troponin I and cardiac troponinT in dogs with class IV congestive heart failure due to mitral valve disease. Journal of Veterinary Emergency and Critical Care. 17, 243–249.

O’Brien, P.J., O’Brien P.J., Reagan W.J., York M.J. (2011). Review of Qualification Data for Cardiac Troponins Center for Drug Evaluation and Research U.S. Food and Drug Administrati. 70.

Lilly, L.S. (2003). Patophysiology of heart disease. Leonard Lippincott Williams and Wilkins. 93–96

Adams, J.E., Bodor G.S., Davila–Roman V.G. Cardiac troponin I: A marker with high specificity for cardiac injury Circulation 88, 101–116.

DeFrancesko, T. (2011). Cardiac biomarkers NAVC Clinician’s Brief. 15–19

Schober, K.E. Kirbach B., Cornand C. (2001). Circulating cardiac troponins in small animals. Denver, 2–3.

Undhad, V.V., Fefar D.T., Jivan. B.M. (2012). Cardiac troponin: an emerging cardiac biomarker in animal health. Vet. World. 5(8) 508–511.

Abstract views: 87
PDF Downloads: 128
Published
2016-10-10
How to Cite
Varkholiak, I. (2016). THE USAGE OF MEDICINES AT THE CARDIOVASCULAR PATHOLOGIES IN DOGS AND CATS. Scientific Messenger of LNU of Veterinary Medicine and Biotechnologies. Series: Veterinary Sciences, 18(3(71), 261-265. Retrieved from https://nvlvet.com.ua/index.php/journal/article/view/974